tHEORetically Speaking
Avsnitt

Weekly News Roundup — Real-Time Clinical Trials, Canadian Breast Cancer Standards, and FDA Data Integrity Concerns

tHEORetically Speaking
Dela

This week’s tHEORetically Speaking News Roundup covers the FDA’s new real-time clinical trial initiative utilizing AI for faster drug development, and Breast Cancer Canada’s new unified national recommendations to eliminate regional disparities in care. We also break down the FDA’s proposal to withdraw Amgen’s Tavneos over data integrity issues and safety concerns.

Register for the WODC USA here: https://www.terrapinn.com/WODC/US/2026/HealthEconomics

Use code HE25 for an extra 25% off your registration fee!

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör HealthEconomics.com. Innehållet i podden är skapat av HealthEconomics.com och inte av, eller tillsammans med, Poddtoppen.